- Report
- May 2024
- 125 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- August 2024
- 143 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- September 2024
- 158 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- March 2025
- 130 Pages
Global
From €3973EUR$4,365USD£3,406GBP
€4414EUR$4,850USD£3,784GBP
- Report
- September 2021
- 115 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2023
- 160 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- February 2025
- 85 Pages
India
From €3185EUR$3,500USD£2,731GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- December 2023
- 255 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- December 2023
- 80 Pages
India
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1365EUR$1,500USD£1,170GBP
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
Poland
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1365EUR$1,500USD£1,170GBP
- Report
- October 2023
- 180 Pages
Global
From €2275EUR$2,500USD£1,951GBP

The Pneumococcal Polysaccharide Vaccine (PPV) is a vaccine used to protect against infections caused by the bacterium Streptococcus pneumoniae. It is recommended for adults over the age of 65, as well as those with certain medical conditions, such as asthma, diabetes, and heart disease. The vaccine is administered as a single injection, and is usually given in combination with other vaccines. It is also recommended for children aged 2-5 years, and for those who are at high risk of developing pneumococcal disease.
PPV is a widely used vaccine, and is available in many countries around the world. It is typically administered in combination with other vaccines, such as the influenza vaccine, and is often given in combination with other vaccines in a single injection.
The PPV market is highly competitive, with many companies offering the vaccine. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more